FDA Inspection 1311632 — Reliance Life Sciences Private Limited
The FDA completed an inspection of Reliance Life Sciences Private Limited on Feb 27, 2026 in Navi Mumbai. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Feb 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Navi Mumbai (India)